中文 | English
Return
Total: 125 , 1/13
Show Home Prev Next End page: GO
MeSH:(Transcription Factors/immunology)

1.Research progress in heterogeneity of human CD4(+)FOXP3(+)T cells.

Jin-Ge XU ; Ling-Song CHEN

Journal of Experimental Hematology 2011;19(6):1528-1531

2.How are MCPIP1 and cytokines mutually regulated in cancer-related immunity?

Ruyi XU ; Yi LI ; Yang LIU ; Jianwei QU ; Wen CAO ; Enfan ZHANG ; Jingsong HE ; Zhen CAI

Protein & Cell 2020;11(12):881-893

3.Recent advances of CD4(+)CD25(+) regulatory T cells in pathogenesis of idiopathic thrombocytopenic purpura - review.

Lu-Juan ZHANG ; Yu ZHANG

Journal of Experimental Hematology 2008;16(4):950-953

4.Immunoregulatory Effect of Adipose Mesenchymal Stem Cells on Peripheral Blood Lymphocytes in Psoriasis Vulgaris Patients.

Xiu Ping YIN ; Rong Jia ZHU ; Chen ZHUANG ; Shuo WANG ; Chun Hua ZHAO ; Ping SONG

Acta Academiae Medicinae Sinicae 2018;40(6):790-796

5.An increased ratio of Th2/Treg cells in patients with moderate to severe asthma.

Yu-Heng SHI ; Guo-Chao SHI ; Huan-Ying WAN ; Xiang-Yan AI ; Hai-Xing ZHU ; Wei TANG ; Jia-Yun MA ; Xiao-Yan JIN ; Bo-Ying ZHANG

Chinese Medical Journal 2013;126(12):2248-2253

6.Targeting Foxp3+ regulatory T cells-related immunosuppression for cancer immunotherapy.

Li-Li FENG ; Xin WANG

Chinese Medical Journal 2010;123(22):3334-3342

7.Perspectives on the role of mTORC2 in B lymphocyte development, immunity and tumorigenesis.

Adam S LAZORCHAK ; Bing SU

Protein & Cell 2011;2(7):523-530

8.Genetic controls of Th17 cell differentiation and plasticity.

Chen DONG

Experimental & Molecular Medicine 2011;43(1):1-6

9.Transcription factor FOXP3 and reproduction.

Xin-Yi XIA ; Xin ZHOU ; Yu-Feng HUANG

National Journal of Andrology 2009;15(7):642-645

10.Prevalence of Foxp3 Positive T Regulatory Cells is Increased during Progression of Cutaneous Squamous Tumors.

Tae Jung JANG

Yonsei Medical Journal 2008;49(6):942-948

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 125 , 1/13 Show Home Prev Next End page: GO